Department of Gastroenterology, Seth GS Medical College and KEM Hospital, Mumbai, India
Copyright © 2020 Korean Society of Gastrointestinal Endoscopy
This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
Conflicts of Interest: The authors have no financial conflicts of interest.
Author Contributions
Conceptualization: Suprabhat Giri, Sridhar Sundaram
Data curation: SG, SS
Formal analysis: SG, SS
Investigation: SG, SS, Harish Darak, Sanjay Kumar
Methodology: SG, SS, HD, SK
Project administration: SS, HD, SK, Shobna Bhatia
Resources: SS, HD, SK, SB
Software: SG, SS, HD, SK
Supervision: SS
Validation: SS, SB
Visualization: SG, SS, SB
Writing-original draft: SG, SS, SB
Writing-review&editing: SG, SS, HD, SK, SB
n=71 | |
---|---|
Age, yr | 46±15 |
Male, n (%) | 43 (60.5) |
Etiologies, n (%) | |
Post-cholecystectomy | 34 (47.8) |
Liver abscess | 20 (28.1) |
Hydatid cyst surgery | 11 (15.4) |
Other surgeries | 5 (7.0) |
Trauma | 1 (1.4) |
Clinical features, n (%) | |
Bile in drain output | 69 (97.1) |
Abdominal pain | 33 (46.4) |
Jaundice | 23 (32.3) |
Fever | 18 (25.3) |
Interval between diagnosis and ERCP, n (%) | |
Within one day | 15 (21.1) |
Within 2–3 days | 19 (26.7) |
>3 days | 37 (52.1) |
n=71 | |
---|---|
Successful CBD cannulation | 71 (100%) |
Site of bile leak on ERCP, n (%) | |
Cystic duct stump | 23 (32.4) |
CBD | 7 (9.8) |
CHD | 3 (4.2) |
RHD | 23 (32.4) |
LHD | 6 (8.4) |
Right aberrant duct | 2 (2.8) |
Smaller peripheral branches | 7 (9.8) |
Other findings, n (%) | |
CBD stones | 3 (4.2) |
Size of stent used, n (%) | |
7 Fr × 10 cm | 2 (2.8) |
7 Fr × 12 cm | 12 (17.1) |
7 Fr × 15 cm | 3 (4.2) |
10 Fr × 10 cm | 46 (65.7) |
10 Fr × 12 cm | 7 (10) |
Complications, n (%) | |
Pancreatitis | 4 (5.6) |
Post-ERCP bleeding | 1 (1.4) |
n=39 | |
---|---|
Strasberg classification, n (%) | |
A (cystic duct stump) | 23 (58.9) |
B | 0 |
C (right aberrant duct injury) | 2 (5.1) |
D | 13 (33.3) |
RHD | 5 |
LHD | 3 |
CBD | 5 |
E (complete transection of CBD) | 1 (2.5) |
Major bile duct injury, n (%) | 14 (35.8) |
Minor bile duct injury, n (%) | 25 (64.1) |
Outcomes | n=71 |
---|---|
Primary outcome achieved | 65 (91.5%) |
Requirement for surgery | 1 (1.4%) |
Repeat CBD stenting required | 5 (7.0%) |
In-hospital mortality (%) | 0 |
Length of hospital stay (median, range) | 10 days (6–25) |
Outcomes | Surgical group | Non-surgical group | p-value |
---|---|---|---|
n=39 | n=32 | ||
Primary outcome achieved | 35 | 30 | 0.683 |
Requirement for surgery | 1 | 0 | 1.000 |
Repeat CBD stenting required | 3 | 2 | 1.000 |
In-hospital mortality | 0 | 0 | 1.000 |
Median length of hospital stay | 8 days (6–13) | 11.5 days (7–25) | 0.0001 |
ERCP, endoscopic retrograde cholangiopancreatography.
CBD, common bile duct; CHD, common hepatic duct; ERCP, endoscopic retrograde cholangiopancreatography; LHD, left hepatic duct; RHD, right hepatic duct.
CBD, common bile duct; LHD, left hepatic duct; RHD, right hepatic duct.
CBD, common bile duct.
CBD, common bile duct.